CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: ZFP14 (ImmuneEditome ID:57677)

1. Gene summary of enriched editing regions for ZFP14

check button Gene summary
Gene informationGene symbol

ZFP14

Gene ID

57677

GeneSynonymsZNF531
GeneCytomap

19q13.12

GeneTypeprotein-coding
GeneDescriptionzinc finger protein 14 homolog|zinc finger protein 531
GeneModificationdate20230518
UniprotIDQ9HCL3;K7EM99
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr19:36338049-36338681:-ENST00000270001.10ENSG00000142065.12ZFP14UTR3AluSz,L1MC5a,AluJbchr19:36338049-36338681:-.alignment


Top

2. Tumor-specific enriched editing regions for ZFP14


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
ENSG00000142065.12,ZFP14BRCAEAG3.7763e-02image
ENSG00000142065.12,ZFP14THCAEAG1.2658e-03image
ENSG00000142065.12,ZFP14UCECEAG4.7600e-02image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
ENSG00000142065.12,ZFP14THCAPathEAG4.1887e-021.0138e-020.1199image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot

Top

3. Enriched editing regions and immune related genes for ZFP14


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark

More results



Top

4. Enriched editing regions and immune related splicing for ZFP14


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
ENSG00000142065.12,ZFP14
GBMEAGESENSG00000147044.16chrX41555599:41555635:41557031:41557100:41559778:41559847-0.40022.3909e-031.0877e-06-0.4080imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CNBP;CSTF2T;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LIN28;LIN28A;LIN28B;MBNL2;MOV10;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RBFOX2;RBM10;RBM47;RC3H1;SAFB2;SRSF1;SRSF3;SRSF9;TAF15;TARDBP;TIA1;U2AF1;U2AF2;UPF1CASKT_cells_follicular_helperGSVA_HALLMARK_BILE_ACID_METABOLISM
ENSG00000142065.12,ZFP14
GBMEAGIRENSG00000153406.9chr164461679:4461959:4463419:4463512-0.39441.1228e-036.1189e-06-0.4028imageNACIN1;AUH;BCCIP;BUD13;CELF2;CSTF2T;DDX54;DGCR8;DKC1;EIF4A3;ELAVL1;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LIN28;LIN28A;LIN28B;MBNL2;MSI2;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;RBFOX2;RBM27;RNF219;SAFB2;SRSF1;SRSF9;TAF15;TARDBP;TIA1;U2AF1;U2AF2;UPF1;ZNF184NAMacrophages_M0GSVA_HALLMARK_FATTY_ACID_METABOLISM
ENSG00000142065.12,ZFP14
GBMEAGESENSG00000103540.12chr1619547954:19548014:19548514:19548600:19551195:195514770.36104.1719e-031.3024e-070.4684imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CNBP;CSTF2T;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LIN28;LIN28A;LIN28B;MBNL2;MOV10;MSI2;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RBFOX2;RBM10;RBM27;RBM47;RC3H1;RNF219;SAFB2;SRSF1;SRSF3;SRSF9;TAF15;TARDBP;TIA1;U2AF1;U2AF2;UPF1;ZNF184CCP110Macrophages_M0GSVA_HALLMARK_SPERMATOGENESIS
ENSG00000142065.12,ZFP14
GBMEAGIRENSG00000226742.3chr1879966611:79966678:79968088:79968183-0.37521.9619e-035.2756e-06-0.4153imageNACIN1;ADAR;AUH;BCCIP;BUD13;CELF2;CSTF2T;DDX54;DGCR8;DHX9;EIF4A3;ELAVL1;FAM120A;FBL;FUS;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP3;KHDRBS2;LIN28;LIN28B;MOV10;NOP56;NOP58;NUMA1;PCBP2;PRPF8;RBFOX2;RBM47;SRSF1;SRSF3;SRSF9;TAF15;TIA1;U2AF1;U2AF2;UPF1;ZNF184HSBP1L1T_cells_follicular_helperGSVA_HALLMARK_XENOBIOTIC_METABOLISM
ENSG00000142065.12,ZFP14
GBMEAGA3ENSG00000103540.12chr1619547954:19548014:19551195:19551477:19548514:19551477-0.37013.1433e-039.0839e-08-0.4716imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CNBP;CSTF2T;DDX54;DGCR8;DHX9;DKC1;EIF4A3;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FUS;FXR1;FXR2;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPK;HNRNPL;HNRNPM;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LIN28;LIN28A;LIN28B;MBNL2;MOV10;MSI2;NOP56;NOP58;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RBFOX2;RBM10;RBM27;RBM47;RC3H1;RNF219;SAFB2;SRSF1;SRSF3;SRSF9;TAF15;TARDBP;TIA1;U2AF1;U2AF2;UPF1;ZNF184CCP110Macrophages_M0GSVA_HALLMARK_G2M_CHECKPOINT
ENSG00000142065.12,ZFP14
GBMEAGIRENSG00000204314.6chr632153339:32153836:32154237:32154333-0.28802.9379e-026.3145e-06-0.4228imageNADAR;BCCIP;BUD13;CSTF2T;DKC1;EIF4A3;FAM120A;FBL;FUS;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPU;HNRNPUL1;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LIN28B;NOP56;NOP58;PCBP2;PRPF8;PTBP1;RBFOX2;RBM27;SAFB2;SRSF1;SRSF3;SRSF9;TAF15;TARDBP;U2AF1;U2AF2;UPF1;ZNF184NAMonocytesGSVA_HALLMARK_MITOTIC_SPINDLE

More results



Top

5. Enriched editing regions and immune infiltration for ZFP14


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
ENSG00000142065.12,ZFP14BLCAEAGDendritic_cells_resting2.8103e-02-0.1619image
chr19:36338049-36338681:-BRCAEERMast_cells_resting1.5460e-02-0.0819image
ENSG00000142065.12,ZFP14CESCEAGT_cells_CD4_memory_activated1.9363e-020.2290image
ENSG00000142065.12,ZFP14COADEAGMacrophages_M01.6953e-02-0.3047image
ENSG00000142065.12,ZFP14ESCAEAGT_cells_regulatory_(Tregs)1.3280e-02-0.2867image
ENSG00000142065.12,ZFP14GBMEAGMacrophages_M03.6533e-03-0.2504image
ENSG00000142065.12,ZFP14HNSCEAGPlasma_cells1.2393e-020.3413image
ENSG00000142065.12,ZFP14KICHEAGT_cells_follicular_helper2.7608e-030.4406image
ENSG00000142065.12,ZFP14KIRCEAGMacrophages_M21.7554e-03-0.1790image
ENSG00000142065.12,ZFP14KIRPEAGEosinophils7.2140e-030.2515image
ENSG00000142065.12,ZFP14LAMLEAGNK_cells_activated1.6942e-02-0.2395image
chr19:36338049-36338681:-LGGEERT_cells_CD4_memory_resting7.6395e-03-0.1295image
ENSG00000142065.12,ZFP14LGGEAGT_cells_CD4_memory_resting1.1912e-02-0.1191image
ENSG00000142065.12,ZFP14LIHCEAGT_cells_gamma_delta4.4606e-020.2540image
chr19:36338049-36338681:-OVEERMacrophages_M04.3253e-03-0.2365image
ENSG00000142065.12,ZFP14OVEAGMacrophages_M16.0411e-040.2274image
ENSG00000142065.12,ZFP14PAADEAGMonocytes5.7534e-030.2938image
chr19:36338049-36338681:-PCPGEERT_cells_CD85.3102e-030.2781image
ENSG00000142065.12,ZFP14PCPGEAGNK_cells_resting6.5896e-030.2564image
chr19:36338049-36338681:-PRADEERMacrophages_M21.3017e-020.1447image
ENSG00000142065.12,ZFP14PRADEAGMast_cells_resting9.3316e-030.1429image
ENSG00000142065.12,ZFP14READEAGT_cells_gamma_delta4.4017e-02-0.4546image
chr19:36338049-36338681:-SARCEERDendritic_cells_resting4.2399e-02-0.2133image
chr19:36338049-36338681:-SKCMEERT_cells_gamma_delta2.3675e-030.2182image
ENSG00000142065.12,ZFP14SKCMEAGT_cells_gamma_delta1.5662e-020.1635image
ENSG00000142065.12,ZFP14STADEAGT_cells_CD4_memory_activated3.5495e-020.1609image
ENSG00000142065.12,ZFP14TGCTEAGMast_cells_resting2.9794e-020.2372image
chr19:36338049-36338681:-THCAEERT_cells_CD4_memory_activated5.6629e-030.1308image
ENSG00000142065.12,ZFP14THCAEAGDendritic_cells_resting9.9328e-030.1200image
ENSG00000142065.12,ZFP14THYMEAGT_cells_follicular_helper6.7076e-030.3258image
chr19:36338049-36338681:-UCSEERT_cells_CD4_memory_activated3.5543e-020.3988image
ENSG00000142065.12,ZFP14UCSEAGT_cells_gamma_delta2.6070e-020.3608image


Top

6. Enriched editing regions and immune gene sets for ZFP14


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chr19:36338049-36338681:-BRCAEER7.8745e-070.16611.2184e-030.10923.4466e-040.12081.1503e-070.1781image
ENSG00000142065.12,ZFP14BRCAEAG1.8592e-040.12261.9287e-020.07692.8632e-020.07202.9335e-070.1676image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
chr19:36338049-36338681:-BLCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEER8.2602e-060.3632image
ENSG00000142065.12,ZFP14BLCAGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG1.3109e-040.2782image
chr19:36338049-36338681:-BRCAGSVA_HALLMARK_UV_RESPONSE_UPEER1.3211e-090.2033image
ENSG00000142065.12,ZFP14BRCAGSVA_HALLMARK_UV_RESPONSE_UPEAG9.3108e-110.2109image
ENSG00000142065.12,ZFP14CESCGSVA_HALLMARK_IL2_STAT5_SIGNALINGEAG1.6441e-040.3613image
ENSG00000142065.12,ZFP14COADGSVA_HALLMARK_MTORC1_SIGNALINGEAG1.9730e-02-0.2979image
ENSG00000142065.12,ZFP14ESCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG3.4943e-020.2456image
ENSG00000142065.12,ZFP14GBMGSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALINGEAG1.4713e-05-0.3660image
ENSG00000142065.12,ZFP14KICHGSVA_HALLMARK_APICAL_SURFACEEAG1.2493e-02-0.3736image
ENSG00000142065.12,ZFP14KIRCGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEAG5.6362e-030.1587image
ENSG00000142065.12,ZFP14KIRPGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG4.4934e-020.1890image
ENSG00000142065.12,ZFP14LAMLGSVA_HALLMARK_HYPOXIAEAG3.0145e-020.2180image
ENSG00000142065.12,ZFP14LGGGSVA_HALLMARK_MITOTIC_SPINDLEEAG4.8934e-11-0.3050image
chr19:36338049-36338681:-LGGGSVA_HALLMARK_MITOTIC_SPINDLEEER3.2566e-07-0.2453image
ENSG00000142065.12,ZFP14LIHCGSVA_HALLMARK_DNA_REPAIREAG7.8341e-03-0.3321image
chr19:36338049-36338681:-LUSCGSVA_HALLMARK_P53_PATHWAYEER1.6427e-020.1654image
ENSG00000142065.12,ZFP14MESOGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.8269e-020.4983image
ENSG00000142065.12,ZFP14OVGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG3.7559e-040.2356image
chr19:36338049-36338681:-OVGSVA_HALLMARK_PEROXISOMEEER1.4638e-020.2031image
ENSG00000142065.12,ZFP14PAADGSVA_HALLMARK_UV_RESPONSE_DNEAG3.7244e-02-0.2237image
ENSG00000142065.12,ZFP14PCPGGSVA_HALLMARK_G2M_CHECKPOINTEAG4.6176e-03-0.2670image
chr19:36338049-36338681:-PRADGSVA_HALLMARK_FATTY_ACID_METABOLISMEER3.2849e-030.1709image
ENSG00000142065.12,ZFP14PRADGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG8.1681e-040.1834image
ENSG00000142065.12,ZFP14READGSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAYEAG1.7399e-02-0.5252image
chr19:36338049-36338681:-SARCGSVA_HALLMARK_ANDROGEN_RESPONSEEER5.4747e-030.2889image
ENSG00000142065.12,ZFP14SARCGSVA_HALLMARK_MYOGENESISEAG8.6276e-030.2504image
ENSG00000142065.12,ZFP14SKCMGSVA_HALLMARK_UV_RESPONSE_UPEAG2.7218e-020.1496image
ENSG00000142065.12,ZFP14STADGSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATIONEAG1.7916e-030.2371image
chr19:36338049-36338681:-STADGSVA_HALLMARK_PANCREAS_BETA_CELLSEER3.4015e-020.2101image
ENSG00000142065.12,ZFP14TGCTGSVA_HALLMARK_MITOTIC_SPINDLEEAG9.2763e-03-0.2823image
ENSG00000142065.12,ZFP14THCAGSVA_HALLMARK_COAGULATIONEAG1.9589e-060.2195image
chr19:36338049-36338681:-THCAGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEER3.0228e-050.1962image
ENSG00000142065.12,ZFP14THYMGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEAG4.1237e-050.4758image
ENSG00000142065.12,ZFP14UCECGSVA_HALLMARK_CHOLESTEROL_HOMEOSTASISEAG8.4294e-030.2792image
chr19:36338049-36338681:-UCSGSVA_HALLMARK_UV_RESPONSE_UPEER4.1183e-020.3883image


Top

7. Enriched editing regions and drugs for ZFP14


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000142065.12,ZFP14ACCCyclopamineEAG4.2333e-020.3186image
chr19:36338049-36338681:-BLCACGP.60474EER5.3769e-04-0.2859image
ENSG00000142065.12,ZFP14BLCACGP.60474EAG3.8975e-03-0.2118image
chr19:36338049-36338681:-BRCACCT007093EER6.3008e-060.1521image
ENSG00000142065.12,ZFP14BRCAA.770041EAG2.8038e-06-0.1535image
ENSG00000142065.12,ZFP14CESCCI.1040EAG8.0131e-05-0.3769image
ENSG00000142065.12,ZFP14COADCCT007093EAG3.9756e-02-0.2640image
ENSG00000142065.12,ZFP14GBMBAY.61.3606EAG1.6141e-070.4355image
ENSG00000142065.12,ZFP14HNSCBMS.509744EAG2.6342e-020.3051image
ENSG00000142065.12,ZFP14KICHGW.441756EAG4.1816e-03-0.4234image
ENSG00000142065.12,ZFP14KIRCCCT018159EAG1.0394e-03-0.1875image
ENSG00000142065.12,ZFP14KIRPBMS.754807EAG1.3593e-02-0.2316image
ENSG00000142065.12,ZFP14LGGCisplatinEAG2.8678e-070.2404image
chr19:36338049-36338681:-LGGLenalidomideEER1.0959e-040.1870image
ENSG00000142065.12,ZFP14LIHCEtoposideEAG3.5118e-020.2660image
ENSG00000142065.12,ZFP14LUADEmbelinEAG1.8961e-020.1570image
chr19:36338049-36338681:-LUSCCCT007093EER4.3302e-030.1961image
ENSG00000142065.12,ZFP14LUSCCEP.701EAG2.6369e-02-0.1468image
ENSG00000142065.12,ZFP14MESOBI.D1870EAG8.8530e-030.5441image
ENSG00000142065.12,ZFP14OVBexaroteneEAG4.4592e-030.1893image
chr19:36338049-36338681:-OVBMS.708163EER2.4256e-03-0.2508image
chr19:36338049-36338681:-PCPGBMS.708163EER3.4244e-02-0.2130image
ENSG00000142065.12,ZFP14PCPGJNK.9LEAG1.3535e-040.3544image
ENSG00000142065.12,ZFP14PRADEHT.1864EAG9.1411e-04-0.1817image
chr19:36338049-36338681:-PRADEHT.1864EER1.3112e-04-0.2212image
ENSG00000142065.12,ZFP14READDMOGEAG4.3756e-02-0.4551image
chr19:36338049-36338681:-SARCIPA.3EER1.8605e-030.3219image
ENSG00000142065.12,ZFP14SARCIPA.3EAG2.3793e-050.3929image
chr19:36338049-36338681:-SKCMBIBW2992EER9.0034e-03-0.1880image
ENSG00000142065.12,ZFP14SKCMBMS.509744EAG3.6685e-02-0.1416image
ENSG00000142065.12,ZFP14STADBMS.536924EAG1.4061e-03-0.2423image
chr19:36338049-36338681:-STADABT.888EER5.6135e-030.2724image
ENSG00000142065.12,ZFP14TGCTGDC.0449EAG3.9001e-03-0.3117image
ENSG00000142065.12,ZFP14THCACI.1040EAG6.7744e-10-0.2823image
chr19:36338049-36338681:-THCAKU.55933EER2.0365e-05-0.2003image
ENSG00000142065.12,ZFP14THYMEmbelinEAG3.0350e-050.4829image
ENSG00000142065.12,ZFP14UCECKU.55933EAG2.4186e-02-0.2402image
chr19:36338049-36338681:-UCSCGP.60474EER2.8250e-02-0.4146image
ENSG00000142065.12,ZFP14UCSCisplatinEAG2.7932e-02-0.3567image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType